VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹26 Cr | ₹21 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr |
What is the latest Capital Work in Progress ratio of VENUS REMEDIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹25 Cr |
How is Capital Work in Progress of VENUS REMEDIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 25.17 | |
| Mar2024 | ₹21 Cr | -19.21 | |
| Mar2023 | ₹26 Cr | 3.43 | |
| Mar2022 | ₹25 Cr | 0.49 | |
| Mar2021 | ₹25 Cr | - | |
Compare Capital Work in Progress of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,451.2 Cr | 13% | 3% | 205.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 13% |
3% |
205.5% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses